IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Regeneron Pharmaceuticals, Inc.

Q3 2025 Holdings

Filed 2025-11-07 | 4 holdings | $700.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Alnylam Pharmaceuticals, Inc.(ALNY)Common Stock02043Q107$634.9M1,392,30390.6%
Intellia Therapeutics, Inc.(NTLA)Common Stock45826J105$64.0M3,702,9959.1%
Adverum Biotechnologies, Inc.(AVU0)Common Stock00773U207$819.5K180,9090.1%
Adicet Bio, Inc.(TORCEUR)Common Stock007002108$784.4K968,1830.1%